We are proud to announce that Etichub has filed a European patent for Dermalsync®, a groundbreaking innovation in skincare treatment. This advanced technology is specifically designed to recognize and adapt to the natural monthly changes in women’s skin, providing a highly personalized solution. Dermalsync® is the result of extensive research conducted by Etichub and a clinical study involving 200 women, giving us a deep understanding of the impact of fluctuating estrogen and progesterone levels on the skin.
Dermalsync®: A Personalized Approach to Skincare
Dermalsync® represents a significant breakthrough in skincare by providing a treatment system that adapts to hormonal and skin changes unique to each phase of the menstrual cycle. This personalized approach enhances every woman’s natural beauty, offering effective, targeted treatments that meet the skin’s ever-evolving needs.
Introducing “Pure & Glow” – The First Dermalsync®-Powered Product
The first product powered by Dermalsync® is the “Pure & Glow” kit, designed specifically for women of reproductive age. This kit includes specialized formulations for each phase of the month, creating a comprehensive skincare and cleansing routine that supports skin wellness at any age. Ingredients are meticulously chosen to meet skin needs during different hormonal stages, while the textures are crafted to align with women’s emotional experiences.
Advancing Innovation with the Dermalsync® Patent
Filing the European patent for Dermalsync® marks a critical milestone in our commitment to providing cutting-edge solutions. This achievement is the result of close collaboration between our testing labs and R&D department, reflecting our dedication to innovation.
With the European patent, we are now ready to integrate this cosmetic breakthrough into our range of services, delivering tangible value for those who have trusted our expertise for years to elevate their products.